earnings
AMEX · ATNM
Actinium Pharmaceuticals, Inc.
Healthcare · Biotechnology
$1.20
Down-$0.09 (-7.50%)
Updated Oct 6, 2026, 11:54 PM
SID Score
4.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 45.55M
- P/E ratio
- -1.32
- Dividend yield
- 0.00%
- 52-week range
- $0.74 – $1.74
- Volume
- 115.03K
- Avg. volume
- 205.89K
Price performance · ATNM
ATNM price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
ATNM closed at $1.20 after 20 trading sessions, down 2.44% for the selected period.
- Last close
- $1.20
- Period change
- -2.44%
- Period low
- $1.12
- Period high
- $1.40
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $1.16 | $1.24 | $1.16 | $1.20 | 115.03K |
| Oct 2, 2026 | $1.15 | $1.19 | $1.12 | $1.17 | 81.8K |
| Oct 1, 2026 | $1.11 | $1.15 | $1.11 | $1.15 | 90.83K |
| Sep 30, 2026 | $1.14 | $1.20 | $1.10 | $1.12 | 95.13K |
| Sep 29, 2026 | $1.17 | $1.17 | $1.14 | $1.14 | 62.02K |
| Sep 28, 2026 | $1.18 | $1.20 | $1.17 | $1.18 | 75.37K |
| Sep 25, 2026 | $1.19 | $1.205 | $1.18 | $1.20 | 28.42K |
| Sep 24, 2026 | $1.19 | $1.25 | $1.18 | $1.19 | 85.94K |
| Sep 23, 2026 | $1.17 | $1.21 | $1.16 | $1.18 | 130.43K |
| Sep 22, 2026 | $1.18 | $1.22 | $1.17 | $1.17 | 54.49K |
| Sep 21, 2026 | $1.24 | $1.24 | $1.166 | $1.20 | 99.38K |
| Sep 18, 2026 | $1.18 | $1.23 | $1.18 | $1.22 | 146.21K |
| Sep 17, 2026 | $1.26 | $1.26 | $1.18 | $1.19 | 57.03K |
| Sep 16, 2026 | $1.26 | $1.275 | $1.24 | $1.24 | 59.77K |
| Sep 15, 2026 | $1.28 | $1.32 | $1.25 | $1.25 | 96.17K |
| Sep 14, 2026 | $1.41 | $1.4183 | $1.25 | $1.28 | 301.51K |
| Sep 11, 2026 | $1.31 | $1.42 | $1.285 | $1.40 | 242.66K |
| Sep 10, 2026 | $1.25 | $1.34 | $1.2301 | $1.31 | 226.76K |
| Sep 9, 2026 | $1.24 | $1.305 | $1.22 | $1.23 | 366.57K |
| Sep 8, 2026 | $1.06 | $1.25 | $1.06 | $1.23 | 574.18K |
Latest ATNM news
The latest Smart Investors Daily articles mentioning ATNM.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…